WARNING ABOUT INCREASED RISK OF CLEFT LIP AND/OR CLEFT PALATE FOLLOWING THE USE OF ZOFRAN® (ONDANSETRON) IN THE FIRST 12 WEEKS OF PREGNANCY.
WARNING ABOUT INCREASED RISK OF CLEFT LIP AND/OR CLEFT PALATE FOLLOWING THE USE OF ONDANSETRON IN THE FIRST 12 WEEKS OF PREGNANCY
FLUOROQUINOLONE ANTIBIOTICS – RISK OF MITRAL AND AORTIC REGURGITATION ASSOCIATED WITH THE USE OF ORAL AND INJECTABLE FLUOROQUINOLONES
